Company: SMNR
Filing Date: 2025-08-14
Form Type: NT 10-Q
Source: 0001213900-25-076842
Chunk: 0

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-14
Form: NT 10-Q
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING</div>

| (Check one): | ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN 
 ☐ Form N-CSR                                                             
 For Period Ended: June 30, 2025                                          |
|:-------------|:-------------------------------------------------------------------------|
|              | ☐ Transition Report on Form 10-K                                         |
|              | ☐ Transition Report on Form 20-F                                         |
|              | ☐ Transition Report on Form 11-K                                         |
|              | ☐ Transition Report on Form 10-Q                                         |
|              | For the Transition Period Ended:                                         |

| Read Instruction (on back page) Before Preparing Form. Please Print or Type.                                        
 Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |

If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:

PART I – REGISTRANT INFORMATION

| Denali Capital Acquisition Corp.                          |
| Full Name of Registrant                                   |
| N/A                                                       |
| Former Name if Applicable                                 |
| 437 Madison Avenue, 27th Floor                            |
| Address of Principal Executive Office (Street and Number) |
| New York, New York 10022                                  |
| City, State and Zip Code                                  |

PART II – RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort
or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

| (a) | The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |

| ☒ | -b | The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or